Log In
Print
BCIQ
Print
Print this Print this
 

AVANCE Nerve Graft

  Manage Alerts
Collapse Summary General Information
Company AxoGen Inc.
DescriptionDecellularized allograft nerves recovered from cadaveric donors
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationNerve damage
Indication DetailsRepair digital nerve damage
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.8M

$20.8M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today